Diversified Enterprises’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
14,584
+431
+3% +$50.4K 0.09% 102
2026
Q1
$1.7M Buy
14,153
+721
+5% +$83.2K 0.09% 105
2025
Q4
$1.41M Buy
13,432
+3,957
+42% +$371K 0.08% 101
2025
Q3
$795K Buy
9,475
+89
+0.9% +$7.33K 0.05% 118
2025
Q2
$743K Sell
9,386
-342
-4% -$27.2K 0.06% 120
2025
Q1
$873K Buy
9,728
+1,004
+12% +$93.7K 0.07% 102
2024
Q4
$868K Buy
8,724
+567
+7% +$58.5K 0.08% 84
2024
Q3
$926K Buy
+8,157
New +$969K 0.1% 77

Other funds holding MRK

Diversified Enterprises's MRK Position: Q2 2026 in Review

Diversified Enterprises increased its Merck (MRK) stake by 3% in Q2 2026, buying an estimated $50.4K and bringing the position to 14,584 shares worth $1.87M. The position accounts for 0.09% of the portfolio, ranked #102.

Diversified Enterprises first reported a position in MRK in Q3 2024 and has held it in 8 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Diversified Enterprises held 14,584 shares of Merck worth $1.87M as of Q2 2026.
  • Diversified Enterprises bought 431 Merck shares in Q2 2026, an estimated $50.4K.
  • Merck made up 0.09% of Diversified Enterprises's portfolio in Q2 2026, its #102 holding.
  • Diversified Enterprises first reported a position in Merck in Q3 2024 and has held it in 8 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.